The article can be accessed here.
"Keep watch also on the faults of the patients which often make them lie about the taking of things prescribed.” Hippocrates
Monday, 21 November 2011
The first publication of ABC Project
Wednesday, 16 November 2011
Predictors of Primary Medication Nonadherence
Fischer et al. Trouble Getting Started: Predictors of Primary Medication Nonadherence
The American Journal of Medicine 124(11);1081.e9-22
Abstract
Background
Patient nonadherence to prescribed medication is common and limits the effectiveness of treatment for many conditions. Most adherence studies evaluate behavior only among patients who have filled a first prescription. The advent of electronic prescribing (e-prescribing) systems provides the opportunity to track initial prescriptions and identify nonadherence that may have previously been undetected.
Methods
We analyzed e-prescribing data and filled claims for all patients with CVS Caremark (Woonsocket, RI) drug coverage who received e-prescriptions from the iScribe e-prescribing system in calendar 2008. We matched e-prescriptions with filled claims by using data on the drug name, date of e-prescription, and date of filled claims, allowing up to 180 days for patients to fill e-prescriptions. We evaluated the rate of primary nonadherence to newly prescribed medications across multiple characteristics of patients, prescribers, and prescriptions and developed multivariable models to identify predictors of nonadherence.
Results
Conclusion
24% of e-prescriptions for new medications were not filled. Our results suggest that interventions to address economic barriers and increase electronic integration in the healthcare system may be promising approaches to improve medication adherence.
To read more click here.
Tuesday, 15 November 2011
Free Medications Could Improve Adherence: MI FREEE trial
Eliminating drug copayments for patients following a myocardial infarction reduced vascular events without increasing overall costs for insurers in the prospective randomized MI FREEE trial.
Although the Post-Myocardial Infarction Free Rx Event and Economic Evaluation trial had only a "modest" impact on medication adherence and missed its primary end point, the findings were dramatic enough that study sponsor Aetna has announced it will waive copayments for its post-MI patients beginning January 2013, lead author Dr. Niteesh Choudhry said at the annual scientific sessions of the American Heart Association.
To read more click here: Internal Medicine News
Subscribe to:
Posts (Atom)